Older adults with attention-deficit/hyperactivity disorder (ADHD) face a higher risk of developing age-related dementias like Alzheimer’s disease. Researchers from the University of Geneva have discovered that they distribute abnormal iron levels similarly in specific brain regions of individuals with dementia-like disorders. This may shed light on the puzzling connection of iron in the brain and these associated disorders.
Iron’s Dual Role in Brain Health
Iron is crucial for normal brain function, supporting oxygen transport, DNA synthesis, and neurotransmitter production. However, excessive iron content in sensitive regions like the neocortex, hippocampus, and basal ganglia triggers oxidative stress. This process damages neurons and leads to their degeneration. As humans age, iron naturally accumulates in these areas. However, there appears to be an accelerated buildup of iron in people with neurodegenerative conditions like Alzheimer’s, Parkinson’s, and Huntington’s diseases.
ADHD brains now show similar iron distribution patterns. A study by Geneva University Hospitals (HUG) and the University of Geneva found that adults with ADHD exhibit elevated iron levels in the precentral cortex (responsible for motor control) and other regions compared to neurotypical individuals.
The team took blood samples to actively measure the neurofilament light chain (NfL) level, a protein released when nerve cells degenerate or suffer damage. When NfL levels are high in the blood, this indicates damage to the brain’s nerve cells, a potential sign of dementia. This iron buildup in the brain seems to be linked to higher levels of NfL, making the correlation between heightened iron levels and neurodegenerative disease.
Key Findings From the Geneva Study
Since iron is easily detectable by MRI scans, researchers used quantitative susceptibility mapping (QSM) MRI to analyze iron distribution in the brain. A group of 32 adults with ADHD and 29 controls aged 25–45 were scanned. The study revealed distinct patterns of iron in the brain within the ADHD participants. Specifically, they found higher concentrations of iron in the brain’s precentral cortex, basal ganglia, and cerebellum.
The team observed that heightened iron levels in the brain were associated with increased NfL levels. This suggests iron-driven axon damage may happen before cognitive decline. Accumulation of iron in the brain also potentially explains hyperactivity and impulsivity seen in ADHD. Researchers noted stimulant medication use in some participants.
Long-term effects of these medications on iron in the brain remain unclear, requiring further investigation. Overall, this research highlights a significant link between iron in the brain and neurological function in individuals with ADHD.
Mechanisms Bridging ADHD and Dementia
Excess iron in the brain creates harmful molecules called free radicals. These free radicals damage nerve cells and speed up tissue breakdown, which is common in both ADHD and dementia. This process, known as oxidative stress, weakens thinking abilities and worsens neurodegenerative diseases by disrupting how energy is produced within cells.
Researchers use a marker called NfL to measure damage to the connections between brain cells (axons). Higher levels of NfL suggest these connections are breaking down, which could explain difficulties with attention in ADHD and memory loss in dementia. Tracking NfL levels may help doctors identify neurodegeneration early on.
Finally, genes that control how iron is processed also play a role in diseases like Alzheimer’s and rare conditions involving too much iron. These genetic factors can influence how much iron builds up in the brain and affect someone’s risk of developing neurological problems. Identifying these predispositions could lead to more personalized treatments.
Clinical Implications and Future Directions
To aptly address neurodegenerative disorders and iron in the brain, we need to focus on three key areas. These three areas of concern are early detection, lifestyle changes, and targeted treatments. Identifying individuals at higher risk is crucial for proactive management and potentially slowing down disease progression.
Medical professionals need to encourage healthy habits like eating a balanced diet rich in antioxidants, exercising regularly, and generally supporting brain health. These lifestyle choices have already shown promise in reducing dementia risk and could be especially helpful for people with ADHD.
Finally, researchers should investigate treatments that specifically reduce iron levels in the brain. While these therapies are currently used for other conditions, they may offer a way to prevent or slow down neurodegenerative processes related to ADHD. More research is needed to ensure their safety and effectiveness for this specific population.
Professor Paul Unschuld, lead psychiatrist of the Geneva study, emphasizes, “Understanding iron’s role opens avenues for reducing dementia risk in ADHD patients through personalized interventions”. This approach could revolutionize how we manage ADHD and related neurodegenerative risks.
The Next Step
Longitudinal studies tracking iron levels, biomarkers, and cognitive outcomes over decades are crucial for developing effective therapeutic treatments. Such research would provide valuable insights into how iron accumulation affects brain health over time and whether interventions can alter disease trajectories. These studies should also explore the impact of lifestyle modifications and medication use on iron dynamics and neurodegenerative risk.
The Role of Lifestyle in Managing ADHD-Related Dementia Risk
Lifestyle interventions offer a promising avenue for reducing dementia risk in ADHD populations. Regular exercise, a balanced diet rich in antioxidants, and stress management techniques can help mitigate oxidative stress and promote brain health. Additionally, avoiding excessive iron intake through dietary supplements is advisable unless medically indicated.
Conclusion
The discovery of iron’s role in ADHD and dementia bridges two seemingly distinct conditions, highlighting shared neurodegenerative pathways. While more research is needed, these insights pave the way for innovative strategies to protect brain health in at-risk populations. By targeting iron dysregulation, clinicians may one day reduce dementia risk for millions living with ADHD.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
Read More: 16 Signs You May Have Iron Deficiency
